OBIO — Orchestra Biomed Holdings Balance Sheet
0.000.00%
- $104.98m
- $52.46m
- $2.64m
Annual balance sheet for Orchestra Biomed Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 8-K | 8-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 35.8 | 10.9 | 83.8 | 87.6 | 66.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.168 | 0.121 | 0.096 | 0.099 | 0.092 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 36.3 | 11.3 | 84.7 | 89.1 | 69.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.03 | 1.12 | 3.68 | 2.83 | 3.49 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 38.1 | 13.5 | 95.6 | 95.2 | 76.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14.4 | 12.2 | 18.6 | 11.2 | 16.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 35.2 | 33.3 | 43 | 27.2 | 43.2 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 2.91 | -19.8 | 52.5 | 68 | 33 |
Total Liabilities & Shareholders' Equity | 38.1 | 13.5 | 95.6 | 95.2 | 76.2 |
Total Common Shares Outstanding |